Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study

Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study

Aims/Introduction Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use is an ongoing postmarketing study of ipragliflozin for long‐term use in Japanese patients with type 2 diabetes mellitus. A subgroup analysis of data from the study was carried ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes investigation 2019-09, Vol.10 (5), p.1262-1271
Hauptverfasser: Tobe, Kazuyuki, Maegawa, Hiroshi, Tabuchi, Hiromi, Nakamura, Ichiro, Uno, Satoshi
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers - analysis
Blood Glucose - metabolism
Blood pressure
Body Mass Index
Body Weight - drug effects
Clinical trials
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - metabolism
Drug dosages
Female
Follow-Up Studies
Glucose
Glucosides - therapeutic use
Glycated Hemoglobin A - analysis
Hemoglobin
Humans
Hypothesis testing
Ipragliflozin
Japan
Laboratories
Male
Middle Aged
Obesity
Original
Patients
Pharmaceutical industry
Population
Postmarketing product surveillance
Product Surveillance, Postmarketing
Prognosis
Safety
Sodium-Glucose Transporter 2 Inhibitors - therapeutic use
Studies
Substance abuse treatment
Technical communication
Thiophenes - therapeutic use
Vital signs
Weight control
Weight Loss - drug effects
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aims/Introduction Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use is an ongoing postmarketing study of ipragliflozin for long‐term use in Japanese patients with type 2 diabetes mellitus. A subgroup analysis of data from the study was carried out to investigate the impact of obesity on the efficacy and safety of ipragliflozin in this population. Materials and Methods Patients were divided into the following subgroups according to their body mass index (BMI):
ISSN:2040-1116
2040-1124
DOI:10.1111/jdi.13021